Related Experiment Videos
2-Chlorodeoxyadenosine: treatment of hairy cell leukemia, chronic lymphocytic leukemia, and lymphocytic lymphoma
1Ida M. and Cecil H. Green Cancer Center, Scripps Clinic and Research Foundation, La Jolla, CA 92037.
Seminars in Hematology
|October 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia.
Leukemia & lymphoma·2016
2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.
Leukemia & lymphoma·2016
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·1999
Reduced charges and costs associated with outpatient autologous stem cell transplantation.
Bone marrow transplantation·1998
Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.
Seminars in hematology·2026
The current state of cerebral complications of sickle cell disease.
Seminars in hematology·2026
Germline predisposition in myeloproliferative neoplasms.
Seminars in hematology·2026
Impact of Ganglionated Plexus Ablation on Early Recurrence After Thoracoscopic Atrial Fibrillation Ablation: A Post Hoc Analysis of the AFACT Study.
Journal of cardiovascular electrophysiology·2026
Tissue-based PEG10 expression as an exploratory biomarker associated with first-line R-CHOP treatment outcome in diffuse large B-cell lymphoma.
Future oncology (London, England)·2026
Systematic Literature Review of the Efficacy and Safety of Treatments in Congenital Thrombotic Thrombocytopenic Purpura.
Journal of blood medicine·2026